Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Aug 20;14(16):1809.
doi: 10.3390/diagnostics14161809.

Diagnostic Performance of Preoperative Calcitonin and Procalcitonin Tests for Differential Diagnosis of Medullary Thyroid Cancer

Affiliations

Diagnostic Performance of Preoperative Calcitonin and Procalcitonin Tests for Differential Diagnosis of Medullary Thyroid Cancer

Il Youb Jeong et al. Diagnostics (Basel). .

Abstract

Medullary thyroid cancer (MTC) shows a relatively poor prognosis among thyroid cancers. Though calcitonin has been used as a diagnostic marker for MTC, it has disadvantages including poor sample stability and discrepancies among results by assay. This study aimed to compare the usefulness of preoperative calcitonin and procalcitonin (PCT) in the diagnosis of MTC. Serum calcitonin and PCT levels were measured before thyroidectomy from MTC (n = 23) and other types of thyroid cancers in patients (n = 1308). Diagnostic performances of calcitonin and PCT for discerning MTC were estimated. In a multivariate analysis, preoperative calcitonin level was independently associated with the diagnosis of MTC, whereas PCT was not. Calcitonin and PCT, respectively, exhibited area under the curve values of 0.997 and 0.979 for the diagnosis of MTC, without significant differences. For calcitonin, the sensitivity, specificity, and positive and negative predictive values were 0.957, 0.992, 0.688, and 0.999, respectively, at a cut-off of 7.2 pg/mL. The corresponding values for PCT were 0.913, 0.995, 0.778, and 0.998 at a cut-off of 0.19 ng/mL. Preoperative calcitonin and PCT showed similar diagnostic utility for MTC. Depending on the patient's clinical status and laboratory environment, these tests can be used as complementary methods for detecting MTC.

Keywords: calcitonin; diagnostic performance; medullary thyroid cancer; procalcitonin.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Diagnostic performances of calcitonin, procalcitonin (PCT), and carcinoembryonic antigen (CEA) for the discrimination of medullary thyroid cancer (MTC) from other histologic types of thyroid cancer. Calcitonin, PCT, and their combination showed excellent diagnostic performance for MTC diagnosis (23 cases and 1308 controls) with the area under the curve (AUC) values greater than 0.97, and the AUC values of the tests were similar to one another (A). In the subgroup of patients with CEA results (13 cases and 50 controls), the AUC values of calcitonin, PCT, and CEA were 0.989, 0.936, and 0.912, respectively, but they were not statistically different (B).

Similar articles

Cited by

References

    1. Oh C.M., Jung K.W., Won Y.J., Shin A., Kong H.J., Lee J.S. Age-Period-Cohort Analysis of Thyroid Cancer Incidence in Korea. Cancer Res. Treat. 2015;47:362–369. doi: 10.4143/crt.2014.110. - DOI - PMC - PubMed
    1. Wells S.A., Jr., Asa S.L., Dralle H., Elisei R., Evans D.B., Gagel R.F., Lee N., Machens A., Moley J.F., Pacini F., et al. Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma. Thyroid. 2015;25:567–610. doi: 10.1089/thy.2014.0335. - DOI - PMC - PubMed
    1. de Groot J.W., Plukker J.T., Wolffenbuttel B.H., Wiggers T., Sluiter W.J., Links T.P. Determinants of life expectancy in medullary thyroid cancer: Age does not matter. Clin. Endocrinol. 2006;65:729–736. doi: 10.1111/j.1365-2265.2006.02659.x. - DOI - PubMed
    1. Trimboli P., Giovanella L. Serum calcitonin negative medullary thyroid carcinoma: A systematic review of the literature. Clin. Chem. Lab. Med. 2015;53:1507–1514. doi: 10.1515/cclm-2015-0058. - DOI - PubMed
    1. Trimboli P., Giovanella L. Procalcitonin as Marker of Recurrent Medullary Thyroid Carcinoma: A Systematic Review and Meta-Analysis. Endocrinol. Metab. 2018;33:204–210. doi: 10.3803/EnM.2018.33.2.204. - DOI - PMC - PubMed

LinkOut - more resources